Evidence map›Paper›PMID 25918934›Full record

ReviewInternational journal of molecular sciences2015

In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment.

Massimo Fantini, Monica Benvenuto, Laura Masuelli, Giovanni Vanni Frajese, Ilaria Tresoldi, Andrea Modesti, Roberto Bei

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 324 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Effect of the Ethanolic Extracts fromInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Massimo FantiniDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome 00133, Italy. kurk84@gmail.com.
Monica BenvenutoDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome 00133, Italy. monicab4@hotmail.it.
Laura MasuelliDepartment of Experimental Medicine, University of Rome "Sapienza", Rome 00164, Italy. Laura.masuelli@uniroma1.it.
Giovanni Vanni FrajeseDipartimento di Scienze Motorie, Umane e della Salute, Università di Roma, Foro Italico, Rome 00194, Italy. frajese@hotmail.com.
Ilaria TresoldiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome 00133, Italy. ilaria3soldi@hotmail.com.
Andrea ModestiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome 00133, Italy. modesti@med.uniroma2.it.
Roberto BeiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome 00133, Italy. bei@med.uniroma2.it.
University of Rome Tor Vergata · ITForo Italico University of Rome · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinogenesis is a multistep process triggered by genetic alterations that activate different signal transduction pathways and cause the progressive transformation of a normal cell into a cancer cell. Polyphenols, compounds ubiquitously expressed in plants, have anti-inflammatory, antimicrobial, antiviral, anticancer, and immunomodulatory properties, all of which are beneficial to human health. Due to their ability to modulate the activity of multiple targets involved in carcinogenesis through direct interaction or modulation of gene expression, polyphenols can be employed to inhibit the growth of cancer cells. However, the main problem related to the use of polyphenols as anticancer agents is their poor bioavailability, which might hinder the in vivo effects of the single compound. In fact, polyphenols have a poor absorption and biodistribution, but also a fast metabolism and excretion in the human body. The poor bioavailability of a polyphenol will affect the effective dose delivered to cancer cells. One way to counteract this drawback could be combination treatment with different polyphenols or with polyphenols and other anti-cancer drugs, which can lead to more effective antitumor effects than treatment using only one of the compounds. This report reviews current knowledge on the anticancer effects of combinations of polyphenols or polyphenols and anticancer drugs, with a focus on their ability to modulate multiple signaling transduction pathways involved in cancer.

Indexed as

AcidsAnimalsAnthocyaninsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBiological AvailabilityCarcinogenesisClinical Trials as TopicDrug Screening Assays, AntitumorFlavonesFlavonoidsHumansIsoflavonesLignansMiceNanotechnologyAcidsAnthocyaninsAntineoplastic AgentsFlavonesFlavonoidsIsoflavonesLignansPhenolsPolyphenolsStilbenes

Identifiers

PMID25918934
PMCPMC4463587
OpenAlexW2039261753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.